Coagulation Testing Market to Jump to Over $1.9 Billion by 2018
(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 04/02/13 -- TriMarkPublications.com cites in its newly published " Markets" report that the coagulation testing market will jump to over $1.9 billion by 2018. For more information, visit: .
can be categorized into two main modalities: central laboratory testing and doctor's office/point of care (POC) testing. The U.S. market will grow to $971 million by 2018 at a CAGR of 4.8%. In U.S. laboratories, the most frequently performed coagulation tests are the prothrombin time (PT) and the activated partial thromboplastin time (aPTT) assays, with estimated annual test volume of 65.9 million and 45.6 million, respectively.
The " Markets" report covers:
Vascular Constriction
Platelet Activation and Platelet Plug Formation
Blood Coagulation
Fibrinolysis
Regulation of Coagulation
Clinical Significance of Blood Coagulation and Anticoagulants
Overview of Commonly Used Drugs to Regulate Coagulation
Situations Requiring Coagulation Testing
Activated Clotting Time (ACT)
Activated Protein C Resistance
Alpha-2 Plasmin Inhibitor
Antiphospholipid Antibody
Antithrombin (Activity and Antigen)
D-Dimer
Ecarin Clotting Time
Euglobulin Lysis
Chemical (Chromogenic) Assays
The " Markets" report examines companies manufacturing equipment and supplies in the world. Companies covered include: Abbott, Accumetrics, Alere, American Labor, Beckman Coulter, Behnk Elektronik, Bio/Data, BioCytex, Cepheid, Chrono-Log, CoaguSense, Diagnostica Stago, Haemonetics, Helena, HYPEN, Instrumentation Laboratory, ITC, LABiTec, Medtronic, Pentapharm, Roche, Sekisui, Siemens, Sienco, Spartan, Sysmex, Tcoag, Technoclone, TECO, Tem and Universal.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: .
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit .
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.04.2013 - 17:00 Uhr
Sprache: Deutsch
News-ID 245237
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Venture Capital
Diese Pressemitteilung wurde bisher 215 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Coagulation Testing Market to Jump to Over $1.9 Billion by 2018"
steht unter der journalistisch-redaktionellen Verantwortung von
TriMarkPublications.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
